Compares dose-effect over 7 years in cervical dystonia patients treated with botulinum toxin A.
To compare the proportion of cervical dystonia (CD) patients treated exclusively with complex-free (incobotulinumtoxinA; CF) or complex-containing (onabotulinumtoxinA or abobotulinumtoxinA; CC) botulinum toxin type A who experienced a worsening in dose–effect (DEff) at year 7 versus year 2.
No takes yet. Share an insight, caveat, or question.
Albrecht et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: